Search by Drug Name or NDC
NDC 59390-0218-05 ALTAFLUOR 4; 2.5 mg/mL; mg/mL Details
ALTAFLUOR 4; 2.5 mg/mL; mg/mL
ALTAFLUOR is a OPHTHALMIC SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Altaire Pharmaceuticals Inc.. The primary component is BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM.
Product Information
| NDC | 59390-0218 |
|---|---|
| Product ID | 59390-218_22a50c28-e476-4966-b68c-065a4b8e157f |
| Associated GPIs | 86806010222010 |
| GCN Sequence Number | 042205 |
| GCN Sequence Number Description | benoxinate HCl/fluorescein sod DROPS 0.4%-0.25% OPHTHALMIC |
| HIC3 | Q6H |
| HIC3 Description | EYE LOCAL ANESTHETICS |
| GCN | 11616 |
| HICL Sequence Number | 002906 |
| HICL Sequence Number Description | BENOXINATE HCL/FLUORESCEIN SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | ALTAFLUOR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fluorescein Sodium and Benoxinate Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 4; 2.5 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM |
| Labeler Name | Altaire Pharmaceuticals Inc. |
| Pharmaceutical Class | Diagnostic Dye [EPC], Dyes [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208582 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59390-0218-05 (59390021805)
| NDC Package Code | 59390-218-05 |
|---|---|
| Billing NDC | 59390021805 |
| Package | 5 mL in 1 BOTTLE, DROPPER (59390-218-05) |
| Marketing Start Date | 2018-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |